Recently Released Market Study: Ukraine Pharmaceuticals & Healthcare Report Q2 2014
Ukraine remains a promising yet risky pharmaceutical market. In 2014, owing to the unstable political and economic situation in the country, drugmakers can expect a challenging business environment and capital outflow restrictions. Exchange rate risks present considerable downside to drugmakers' revenues in the country, and with the threat of price controls and compulsory licensing, Ukraine's Risk/ Reward ratio is worsening. Over the long term, we find the market to be attractive due to an ageing population, demographic trends and a...
View full press release